LG CHEM to supply polio, pentavalent vaccines to UNICEF
14 Mar 2023 12:13pm
picture for illustrative purposes - FILEPIC
Under the deal, LG Chem will provide US$200 million worth of the vaccines: $100 million worth of its polio vaccine, Eupolio, and $100 million worth of the pentavalent vaccine, Eupenta -- the five-in-one vaccine against diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae -- Yonhap news agency reported the company said in a release.
Eupolio will be supplied for two years starting in 2024, and the contract for Eupenta will be effective for five years beginning this year.
LG Chem said the supply can help some 80 million infants and children get immunized against the diseases.
LG Chem's contract accounts for more than 30 percent of the entire procurement volume UNICEF had put up for bidding, according to LG Chem.
LG Chem received the first World Health Organisation’s pre-qualification approval for its hepatitis B vaccine, Euvax, in 1996, before getting the same approval for Eupenta in 2016 and Eupolio in 2020.
LG Chem is in the process of developing a hexavalent vaccine that combines Eupolio and Eupenta, among other combination vaccines, it added - BERNAMA
